Company intelligence / Profile preview

Catheter Precision Inc.

Fort Mill, SC, USAcatheterprecision.com ↗

Ownership: Public · VTAK
Development stage: Commercial

Overview

The company’s LockeT suture retention device has demonstrated immediate hemostasis and short times to ambulation in clinical studies. The VIVO™ non-invasive mapping system has been highlighted in peer-reviewed publications as a meaningful tool for guiding ablation therapy. Ongoing multicenter studies are evaluating both products’ effectiveness and workflow improvements. Over 130 patients have been enrolled in the comparative LockeT II study; European registry data on VIVO™ will be published through 2025.[7]

Therapeutic areas: Cardiovascular
Modalities: Medical devices (catheters, suture retention devices)non-invasive mapping systems[5][8]
Industry: Surgical Medical Devices

Financials

Market cap: $476.6K
Total revenue: $1M
Enterprise value: $2M

Beyond the preview

Go deeper on Catheter Precision Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catheter Precision Inc..

Explore the full profile